Skip to content

TuHURA Biosciences, Inc. HURA Other operating expenses

Other operating expenses at other companies

CTO
Citius Oncology, Inc.CTOR
$29.95M+301%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$30.93M-27.9%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
$14.88M+49.9%
Vera Therapeutics logo
Vera TherapeuticsVERA
$125.13M+119%

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s other operating expenses?
TuHURA Biosciences, Inc. (HURA) reported other operating expenses of $7.53M in Q1 2026.
How has TuHURA Biosciences, Inc.'s other operating expenses changed year-over-year?
TuHURA Biosciences, Inc.'s other operating expenses increased by 7.3% year-over-year, from $7.02M to $7.53M.
What is the long-term trend for TuHURA Biosciences, Inc.'s other operating expenses?
Over 2 years (2023 to 2025), TuHURA Biosciences, Inc.'s other operating expenses has grown at a 3.4% compound annual growth rate (CAGR), from $29.76M to $31.8M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.